National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Genet Med. 2013 Apr;15(4):258-67. doi: 10.1038/gim.2012.157. Epub 2013 Jan 10.
Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. Several institutions have recently begun genomic medicine programs, encountering many of the same obstacles and developing the same solutions, often independently. Recognizing that successful early experiences can inform subsequent efforts, the National Human Genome Research Institute brought together a number of these groups to describe their ongoing projects and challenges, identify common infrastructure and research needs, and outline an implementation framework for investigating and introducing similar programs elsewhere. Chief among the challenges were limited evidence and consensus on which genomic variants were medically relevant; lack of reimbursement for genomically driven interventions; and burden to patients and clinicians of assaying, reporting, intervening, and following up genomic findings. Key infrastructure needs included an openly accessible knowledge base capturing sequence variants and their phenotypic associations and a framework for defining and cataloging clinically actionable variants. Multiple institutions are actively engaged in using genomic information in clinical care. Much of this work is being done in isolation and would benefit from more structured collaboration and sharing of best practices.Genet Med 2013:15(4):258-267.
尽管人们早就预计基因组学有可能为临床护理做出贡献,但将基因组研究结果纳入医学实践的风险和益处的定义速度相对较慢。最近,一些机构已经开始开展基因组医学项目,遇到了许多相同的障碍,并经常独立地开发出相同的解决方案。认识到成功的早期经验可以为后续工作提供信息,国家人类基因组研究所召集了一些这样的团体,描述他们正在进行的项目和挑战,确定共同的基础设施和研究需求,并概述一个调查和在其他地方引入类似项目的实施框架。其中主要的挑战是缺乏关于哪些基因组变异具有医学相关性的有限证据和共识;缺乏对基因组驱动干预的报销;以及对患者和临床医生进行检测、报告、干预和跟踪基因组结果的负担。关键的基础设施需求包括一个开放获取的知识库,用于捕获序列变异及其表型关联,以及一个用于定义和编目临床可行变异的框架。多个机构正在积极参与将基因组信息应用于临床护理。这项工作的大部分都是孤立进行的,需要更结构化的合作和最佳实践的共享。《遗传医学》2013 年 15 卷(4):258-267。